What category does this event fall under?

Business — classified as earnings call.

What is the sentiment of coverage?

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated Jul 07, 2026. Coverage continues to evolve.

Business earnings call

NeoGenomics Q2 2026 earnings date

Q: When did this event occur?

First reported Jul 07, 2026; last updated Jul 07, 2026.

Q: What is the market impact?

General. This is a routine earnings announcement with minimal immediate market impact.

Analysis based on 6 articles · First reported Jul 07, 2026 · Last updated Jul 07, 2026

Sentiment

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

This is a routine earnings announcement with minimal immediate market impact. The actual results and forward guidance will determine any stock movement.

Healthcare Diagnostics

Event Summary

NeoGenomics, Inc. announced it will report its second quarter 2026 financial results after market close on July 28, 2026, followed by a webcast and conference call at 4:30 p.m. ET. The company is a leading provider of oncology diagnostic solutions.

Key Actions

10 NeoGenomics announced earnings date

Entities Involved

stock

NeoGenomics

NeoGenomics is the subject of the event; the earnings report will provide updates on its financial performance and business outlook.

Importance 100.0 Sentiment 0.0

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard